GlassScriptPhysician profile
Jacob Bobba
NPI 1053819946
$5,226.04
in general payments reported to CMS, 2019-2025
29 companies · $1,220 in 2025
The $1,220 reported for 2025 was more than what 92% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $854 · 2022: $1,154 · 2023: $1,065 · 2024: $934 · 2025: $1,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,218.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,874.79 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $955.60 | 2021-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $308.43 | 2021-2024 | Lifevest |
| Davol INC. | $280.82 | 2021 | |
| Scpharmaceuticals INC. | $239.69 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $224.88 | 2022-2025 | Jardiance |
| Baxter Healthcare | $219.19 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $165.28 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $145.11 | 2022-2023 | Camzyos |
| Merck Sharp & Dohme LLC | $141.20 | 2024-2025 | Verquvo |
| Ethicon US, LLC | $115.22 | 2022 | |
| Abbott Laboratories | $87.21 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet, Cardiomems |
| Alnylam Pharmaceuticals INC. | $44.27 | 2024 | Onpattro |
| Smith+Nephew, INC. | $41.11 | 2024-2025 | Pico |
| Terumo Medical Corporation | $36.81 | 2025 | Azur Cx Detachable, Angio-Seal, Glidewire |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $35.28 | 2024 | Vasoview Hemopro 2 |
| Bard Peripheral Vascular, INC. | $33.54 | 2024 | Conquest, Lutonix Drug Coated Balloon |
| Bridgebio Pharma, INC. | $31.50 | 2025 | Attruby |
| Shockwave Medical, INC | $31.07 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $28.82 | 2025 | Enroute Transcarotid Neuroprotection System |
| Terumo Cardiovascular Systems Corporation | $26.33 | 2024 | Virtuosaph Plus With Radial Indication, Terumo Advanced Perfusion System 1, Capiox Fx Advance Hollow Fiber Oxygenator W Integrated Af W Hardshell Res. |
| Inari Medical, INC. | $25.14 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $24.09 | 2024 | Impella |
| Novo Nordisk INC | $23.13 | 2025 | Wegovy |
| Medtronic, INC. | $22.54 | 2022 | |
| Daiichi Sankyo INC. | $19.69 | 2023 | Injectafer |
| Lexicon Pharmaceuticals, INC. | $15.86 | 2024 | |
| Pfizer INC. | $14.83 | 2023 | |
| Icu Medical INC | $14.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Bobba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.